the variance of neural responses. Finally, the estimation of single-trial step times provides a novel view of choice-related activity, revealing that choice-correlated fluctuations in response are also dominated by discrete steplike dynamics.
Although these results challenge the canonical perspective of LIP dynamics during decisionmaking, the approach facilitates new avenues of investigation. Our analyses suggest that accumulation may be implemented by stochastic steps, but simultaneous recordings of multiple neurons will be required to investigate whether population activity ramps or discretely transitions between states on single trials (8) ; population-level ramping could still be implemented via step times that vary across neurons, even on the same trial. Fortunately, the statistical techniques reported here are scalable to simultaneously recorded samples of multiple neurons, and newer recording techniques are starting to yield these multineuron data sets (18) (19) (20) (21) . It is also possible that single neurons with ramping dynamics implement evidence integration elsewhere in the brain and that LIP neurons are postdecisional or premotor indicators of the binary result of this computation. More generally, we believe that these techniques will have broad applicability for identifying and interpreting the latent factors governing multineuron spike responses, allowing for principled tests of the dynamics governing cognitive computations in many brain areas.
Insulin-induced gene 1 (Insig-1) and Insig-2 are endoplasmic reticulum membrane-embedded sterol sensors that regulate the cellular accumulation of sterols. Despite their physiological importance, the structural information on Insigs remains limited. Here we report the high-resolution structures of MvINS, an Insig homolog from Mycobacterium vanbaalenii. MvINS exists as a homotrimer. Each protomer comprises six transmembrane segments (TMs), with TM3 and TM4 contributing to homotrimerization. The six TMs enclose a V-shaped cavity that can accommodate a diacylglycerol molecule. A homology-based structural model of human Insig-2, together with biochemical characterizations, suggest that the central cavity of Insig-2 accommodates 25-hydroxycholesterol, whereas TM3 and TM4 engage in Scap binding. These analyses provide an important framework for further functional and mechanistic understanding of Insig proteins and the sterol regulatory element-binding protein pathway.
C
holesterol homeostasis is essential for human physiology. Aberrant accumulation of sterols contributes to the initiation and progression of atherosclerosis that can lead to heart attack and stroke (1) . Cellular sterol levels are monitored by several membraneembedded proteins, including insulin-induced gene 1 (Insig-1) and Insig-2, which are essential components of the sterol regulatory elementbinding protein (SREBP) pathway that controls cellular lipid homeostasis through a feedback inhibition mechanism (2) (3) (4) (5) .
SREBPs are a family of membrane-anchored transcription factors that activate genes encoding low-density lipoprotein receptor and enzymes for sterol synthesis (6) (7) (8) . SREBP forms a stable complex with SREBP cleavage-activating protein (Scap) through their respective C domains (9-13). The complex is anchored on the endoplasmic reticulum (ER) through interactions between the membranous domain of Scap and Insig-1/-2 in a sterol-dependent manner (14, 15) . Upon cholesterol deprivation, Scap dissociates from Insig-1/-2 and associates with COPII, which translocates the SREBP-Scap complex from the ER to the Golgi (16, 17) . In the lumen of the Golgi, SREBP is cleaved by the membrane-anchored site-1 protease (S1P) and then by the intramembrane site-2 protease (S2P) (18, 19) , allowing its soluble N-terminal transcription factor domain to enter the nucleus for gene activation (20) (21) (22) (23) .
Insig-1/-2 negatively regulate the cellular accumulation of sterols, mainly through two distinct mechanisms. First, upon binding to 25-hydroxycholesterol (25HC), Insig-1/-2 inhibit the exit of the SREBP-Scap complex from the ER, hence preventing transcriptional activation of genes for cholesterol synthesis and uptake (24) . Second, during sterol repletion, Insig-1 recruits the protein degradation machinery to quickly sciencemag.org SCIENCE The trimeric interface is mediated exclusively by hydrophobic residues on TM3 and TM4. Arg77 on TM3 was mutated to Cys for disulfide-bond formation with Cys117 on TM4 from the adjacent protomer. Both residues are labeled red. (E) MvINS is a trimer in solution.Wildtype and cross-linked MvINS-R77C were subjected to size exclusion chromatography. The peak fractions were applied to SDS-polyacrylamide gel electrophoresis followed by Coomassie blue staining. All structure figures were prepared with PyMol (37).
destruct the rate-limiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, blocking cholesterol synthesis (4, 25, 26) .
The major players of the SREBP pathway have been identified for over a decade; however, the only structural information on membrane proteins of this pathway came from an archaeal ortholog of S2P (27) . No bacterial homologs have been identified for SREBP, Scap, or HMG-CoA reductase. Here we report the high-resolution crystal structures of a mycobacterial homolog of Insig proteins. Guided by a homologous structural model of human Insig-2, a number of residues that may contribute to Scap association and 25HC binding were identified and biochemically confirmed.
Using human Insig-1 or -2 as a query, BLAST searches against sequenced bacterial genomes led to the identification of one protein from Mycobacterium vanbaalenii PYR-1. This protein, which we named MvINS, shares sequence identities of 23 and 26% with Insig-1 and -2, respectively (fig. S1), and sequence similarity of 40% with both proteins. Using MvINS as a query, six other proteins, all from mycobacteria, were identified ( fig. S2A ).
Crystals of MvINS in space group R3 appeared in several conditions under different detergents and diffracted x-rays beyond 2.0 Å resolution.
The initial phases were derived from mercurybased single-wavelength anomalous dispersion (Hg-SAD) ( fig. S3A) . The final atomic model of MvINS was refined to 1.9 Å resolution (Fig. 1A,  fig. S3B , and table S1). Consistent with the topological prediction for Insig-1/-2 (24, 28), MvINS comprises six transmembrane segments (TMs), with both the N-and C-termini located on the cytosolic side of the membrane. Given the level of sequence conservation, it is likely that all Insig proteins exhibit the same fold as MvINS.
TM1 and -2, and TM5 and -6, each cross at the middle and are connected by a long segment. The four TMs together form a helical bundle that is tilted counterclockwise (Fig. 1A) . The connecting sequences between TM1 and TM2 form a short b strand, which with the corresponding strand b5-6, caps the cavity enclosed by the helical bundle on the periplasmic side. TM1/TM2 and TM5/TM6 display an internal pseudo twofold symmetry around an axis that is perpendicular to the membrane plane and superimpose with root mean square deviation of 1.49 Å over 60 Ca atoms (Fig. 1B  and fig. S2B ). As found for the corresponding segments in human Insig-2, the N-and C-terminal fragments corresponding to TM1/TM2 and TM5/TM6 share considerable sequence similarity ( fig. S2C ).
There is one MvINS molecule in each asymmetric unit. Examination of the crystal lattice reveals a homotrimeric assembly involving three neighboring symmetry-related molecules (Fig. 1C  and fig. S4A ). The trimeric interface is mediated exclusively through van der Waals interactions between TM3 of one protomer and TM4 of the adjacent protomer (Fig. 1C, 1D ). To examine whether MvINS indeed exists as a homotrimer in solution, we employed a disulfide bond-mediated crosslinking strategy.
Structural analysis showed that Arg77 on TM3 of one protomer and Cys117 on TM4 of the adjacent protomer are both on the cytoplasmic end of the helix with their Ca atoms 5.7 Å apart, ideal targets for disulfide-bond formation (Fig. 1D) . We generated a MvINS variant (MvINS-R77C) with the mutation R77C and two additional cysteines mutated to alanine (C109A/C127A). Upon induction of disulfide-bond formation, MvINS formed a stable homotrimer (fig. S4B ). The fully crosslinked MvINS-R77C and wild-type MvINS were eluted at almost identical volumes on size exclusion chromatography (Fig. 1E) . Structural characterizations confirmed that MvINS-R77C shows the same trimer conformation as the wild type ( fig. S4C and table S2 ).
Within each MvINS protomer, an extended cavity is formed by TM1/2/5/6 below the periplasmic b strands ( Fig. 2A and fig. S5A ). Modeling shows that a diacylglycerol (DAG) molecule with two 14-carbon aliphatic tails can be fitted into the V-shaped cavity. In the structure of MvINS extracted with n-dodecyl-N,N-dimethylamine-N-oxide (LDAO), two elongated strips of electron density filling two arms of the V-shaped cavity became clearly visible after most amino acids were modeled ( Fig. 2A, inset) . These densities probably represent aliphatic lipid or detergent molecules and occupy the DAG-binding site in the course of MvINS overexpression and/or purification.
To investigate whether MvINS can accommodate a DAG molecule, we synthesized a brominederived DAG, where the end methyl group of the Sn-1 fatty acyl chain is substituted by a bromine (Br) atom, and co-crystallized it with MvINS purified in Cymal-7. The structure was determined at 2.1 Å resolution (table S2). The V-shaped electron density, together with the Br anomalous signal, unambiguously confirmed the presence of DAG in the cavity (Fig. 2B) .
The head group and the Sn-1 tail are coordinated by residues from TM1/2/3/6 and the periplasmic b strands, whereas the Sn-2 tail extends into the lipid bilayer through the cleft between TM2 and TM5 (Fig. 2C) . The polar head of the DAG molecule is coordinated through hydrogen bonds by four residues close to the periplasmic side: Asp23 and His26 on TM1, Tyr34 on b1-2, and Tyr150 on b5-6 ( Fig. 2D and fig. S2A ). The completely buried Sn-1 aliphatic tail is surrounded by hydrophobic residues mainly from TM6 and, to a lesser extent, from TM1/2/3 ( fig. S5B ). The partially bound Sn-2 aliphatic chain, on the other hand, is loosely coordinated by a few amino acids, mainly from TM2/5 ( fig. S5C) .
On the basis of MvINS structure and the sequence similarity between MvINS and human Insig proteins ( fig. S1 ), we generated a threedimensional structural model for the transmembrane domain of Insig-1/-2 using the program MOE (29). As human Insig-1 and Insig-2 share 85% sequence identity at the transmembrane region, we focus here on the structural model of Insig-2 ( fig. S6, A and B) . The boundaries of the TMs are largely consistent with the prediction derived from biochemical analysis (24, 28), with some minor shifts. One notable difference concerns the beginning of TM2. In the homologous Insig-2 model, TM2 begins at Ser69, which adds seven extra amino acids to the extended linker sequence preceding TM2, as compared to the previous prediction (24) (fig. S6A ). TM1/ 2/3/5/6 exhibit approximately 30% identity and 50% similarity between MvINS and Insig-2 ( fig.  S1 ). The degree of sequence similarity is probably sufficient for structural modeling of invariant and conserved residues on these five TMs (30) (31) (32) (33) .
In Insig-2, Phe115 is critical for the specific recognition of 25HC (24) . Phe115 is located on the cavity-facing side of TM3 in the homologous model of Insig-2 ( fig. S6C) , suggesting that the central cavity might provide the accommodation for 25HC. The Insig-2 residues Gln132/Trp145/Asp149 mediate interactions with Scap but are not required for 25HC binding (24) . All three residues are located on the outside surface of TM4 in the homologous model of Insig-2, suitably positioned to engage other binding partner(s) (fig. S6C ). However, the corresponding residues of Gln132 and Trp145 on TM4 of MvINS are involved in homotrimerization, which may exclude its interaction with other proteins. We thus examined the oligomerization states of Insig-2. Size exclusion chromatography is consistent with Insig-2 existing as a monomer in solution; thus, TM4 of Insig-2 may be involved in hetero-oligomerization with Scap ( fig. S6D) .
To establish the structure-function correlation, we attempted to reconstitute an assay system to examine the oxysterol-regulated interaction between Insig-2 and Scap. A pull-down assay showed 25HC-dependent complex formation between Insig-2 and Scap (Fig. 3A) . Insig-2 variants that each carry a single point mutation of F115A, Q132A, W145A, or D149A failed to pull down Scap even in the presence of 25HC (Fig. 3B) (24) .
Insig-2 variants each containing a single point mutation on TM3 were generated and their interactions with Scap were examined. Replacement of the outward-protruding residues Ala113, Gly117, or His120 by aromatic residues led to complete disruption of complex formation, even in the presence of 25HC. In contrast, substitution of the residues Val114 or Val116, which appear to mediate intramolecular interactions with adjacent TMs, had no effect on Scap association (Fig. 3C ). These observations suggest that TM3 and TM4 of Insig-2 contribute to Scap binding.
To identify additional residues for 25HC recognition, we examined the pocket residues (Fig.  4A and fig. S7 ). Single point mutation of residues adjacent to Phe115, including G39F, C77D, and G200F, led to abolished or markedly decreased complex formation in the presence of 25HC (Fig. 4A) . These Insig-2 variants showed decreased affinity with 25HC in the direct binding assay (24) (Fig. 4B) . Gly39 (TM1), Cys77 (TM2), and Gly200 (TM6) are clustered together with Phe115 (TM3) within the central cavity, enclosing a ring at approximately mid-height across lipid bilayer.
After the discovery of Insig proteins from mammalian cells (14, 15) , their homologs have been identified in Schizosaccharomyces pombe (34), Saccharomyces cerevisiae (35) , and Aspergillus fumigatus (36) . Despite the moderate sequence homology between mammalian and yeast Insig proteins of typically only 20 to 30% identity, they appear to exhibit functional conservation (35) . Therefore, the structural information reported here for a mycobacterial homolog is consistent with a structural and functional conservation of Insig proteins during evolution ( fig. S8 ). However, no homologs of SREBP, Scap, or HMG-CoA reductase have been found in these mycobacteria, so the physiological function of the bacterial homolog remains a question. A major goal for HIV-1 vaccine development is the production of an immunogen to mimic native, functional HIV-1 envelope trimeric spikes (Env) on the virion surface. We lack a reliable description of a native, functional trimer, however, because of inherent instability and heterogeneity in most preparations. We describe here two conformationally homogeneous Envs derived from difficult-to-neutralize primary isolates. All their non-neutralizing epitopes are fully concealed and independent of their proteolytic processing. Most broadly neutralizing antibodies (bnAbs) recognize these native trimers. Truncation of their cytoplasmic tail has little effect on membrane fusion, but it diminishes binding to trimer-specific bnAbs while exposing non-neutralizing epitopes. These results yield a more accurate antigenic picture than hitherto possible of a genuinely untriggered and functional HIV-1 Env; they can guide effective vaccine development.
H IV-1 envelope glycoprotein (Env) fuses viral and cell membranes, allowing entry of the virus into host cells to initiate infection. The Env polypeptide chain is produced as a precursor, gp160, which trimerizes to (gp160) 3 and then undergoes cleavage into two noncovalently associated fragments: the receptorbinding fragment gp120 and the fusion fragment gp41 (1) . Three copies each of gp120 and gp41 form the mature envelope spike (gp120/gp41) 3 , which is the major viral surface antigen and therefore a critical target for vaccine development. Gp120 binds to host primary receptor CD4 and then to coreceptor (e.g., CCR5 or CXCR4), triggering large conformational changes and a cascade of refolding events in gp41 that lead to membrane fusion (2, 3) (fig. S1 ).
The failure of monomeric gp120 as a vaccine candidate in a large efficacy trial (4, 5) led to the notion that an immunogen mimicking the native, functional envelope trimer would be needed to induce effective, broadly neutralizing antibody (bnAb) responses by vaccination. In particular, bnAbs [except those recognizing the membraneproximal external region (MPER) (6)] were thought to bind only the untriggered, native Env trimer (7). Attempts to produce such an Env preparation have met with only limited success (8, 9) . Moreover, we lack an accurate standard for a native, functional trimer because most Env preparations, both soluble and membrane-bound, including those on the surface of infectious virions, show considerable structural instability and heterogeneity, leading to conflicting interpretations. For instance, based on virus-capturing assays, some groups conclude that certain "non-neutralizing" (including strain-specific neutralizing) epitopes are exposed on the native, functional Env trimer, whereas others believe that there are both functional and nonfunctional Envs present on the surface of infectious viral particles (10-13). Furthermore, the uncleaved ectodomain of trimeric (gp160) 3 , designated gp140, is often considered to mimic the native state of Env. Recombinant gp140 trimers derived from selected strains are stable and homogeneous, with certain desired antigenic properties (14-16), but we cannot know how closely they resemble functional and untriggered Env spikes without a good native-trimer reference. Are these soluble gp140 trimers-all with certain non-neutralizing epitopes (e.g., V3 loop) exposed-really the best surrogate for a native Env trimer. If not, how can we improve them? Recent work on conformational dynamics of the Env spikes on the virion surface suggests that the native trimer transitions among three distinct prefusion conformations (17) . If this is true for difficult-to-neutralize clinical isolates, how can the functional trimer limit access to the non-neutralizing epitopes that overlap with the functionally important sites, such as the CD4 binding site and the V3 loop?
We have previously screened many HIV-1 primary isolates and identified two (clade A 92UG037.8 and clade C C97ZA012) that yield stable, homogeneous gp140 trimers (6, 14) . The two Envs have about 74% sequence identity. Their divergence, typical for cross-clade comparisons, samples a range of Env diversity. Additional stable, clade-C trimers have since been reported (18), but we have not yet detected a clear "stability signature." Our previous immunogenicity studies using either gp120 or gp140 immunogens derived from these two isolates failed to show any autologous
